OSA
Price:
$0.47
Market Cap:
$8.18M
ProSomnus, Inc. manufactures precision oral appliance therapy devices for the treatment of obstructive sleep apnea (OSA). The company was founded in 2016 and is based in Pleasanton, California.
Industry
Medical - Devices
IPO Date
2021-07-28
Stock Exchange
NASDAQ
Ticker
OSA
According to ProSomnus, Inc.’s latest financial reports and current stock price. The company's current ROE is 102.32%. This represents a change of 443.26% compared to the average of 18.84% of the last 4 quarters.
The mean historical ROE of ProSomnus, Inc. over the last ten years is 24.69%. The current 102.32% ROE has changed 314.47% with respect to the historical average. Over the past ten years (40 quarters), OSA's ROE was at its highest in in the September 2023 quarter at 33.68%. The ROE was at its lowest in in the December 2022 quarter at -43.63%.
Average
24.69%
Median
12.15%
Minimum
-16.12%
Maximum
90.58%
Discovering the peaks and valleys of ProSomnus, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 90.58%
Minimum Annual Increase = -661.74%
Minimum Annual ROE = -16.12%
| Year | ROE | Change |
|---|---|---|
| 2023 | 90.58% | -661.74% |
| 2022 | -16.12% | -243.57% |
| 2021 | 11.23% | -14.04% |
The current ROE of ProSomnus, Inc. (OSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
28.56%
5-year avg
24.69%
10-year avg
24.69%
ProSomnus, Inc.’s ROE is greater than Neoleukin Therapeutics, Inc. (-39.98%), less than Biora Therapeutics, Inc. (12.18%), greater than Turnstone Biologics Corp. (-171.86%), greater than Tvardi Therapeutics, Inc. (-115.90%), greater than NeuroMetrix, Inc. (-30.10%), greater than COSCIENS Biopharma Inc. (-149.40%), greater than Omega Therapeutics, Inc. (-173.25%), greater than Holdco Nuvo Group D.G Ltd. Ordinary Shares (-36.55%), less than SunLink Health Systems, Inc. (11.72%), less than Centogene N.V. (397.65%),
| Company | ROE | Market cap |
|---|---|---|
| -39.98% | $8.20M | |
| 12.18% | $994.99K | |
| -171.86% | $8.21M | |
| -115.90% | $39.21M | |
| -30.10% | $9.43M | |
| -149.40% | $6.43M | |
| -173.25% | $7.90M | |
| -36.55% | $5.65M | |
| 11.72% | $7.85M | |
| 397.65% | $9.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProSomnus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProSomnus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ProSomnus, Inc.'s ROE?
How is the ROE calculated for ProSomnus, Inc. (OSA)?
What is the highest ROE for ProSomnus, Inc. (OSA)?
What is the 3-year average ROE for ProSomnus, Inc. (OSA)?
What is the 5-year average ROE for ProSomnus, Inc. (OSA)?
How does the current ROE for ProSomnus, Inc. (OSA) compare to its historical average?